세계의 급성기 의료 신드로믹 검사 시장 규모는 2024년에 31억 2,000만 달러로 평가되었고 예측 기간에는 46억 7,000만 달러에 이르며, 2030년까지의 CAGR은 6.91%를 나타낼 것으로 예상되고 있습니다.
급성기 의료 신드로믹 검사 시장은 건강 관리 환경, 특히 응급실 및 급성기 치료 시설에서 환자의 급성 증상 및 상태의 원인을 신속하게 확인하고 진단하는 데 사용되는 진단 접근법입니다. 이 접근법은 환자의 증상의 원인이 될 수있는 여러 병원체(바이러스, 박테리아 및 기타 미생물 및 기타)를 동시에 검사합니다. 그 목적은 잠재적인 원인을 신속하게 좁히고 적절한 치료 정책을 결정하는 것입니다. 급성기 의료 신드로믹 검사는 환자가 다양한 감염 인자에 기인할 수 있는 증상을 나타내는 상황에서 특히 중요합니다. 이 검사 전략을 통해 건강 관리 제공업체는 환자 관리, 격리 조치 및 치료 옵션과 관련하여 적시에 충분한 정보를 바탕으로 결정을 내릴 수 있습니다. 이 검사는 질병의 유행과 유행에 특히 유용하며, 건강 관리 시스템이 유사한 증상을 가진 많은 환자를 효율적으로 관리하고 대응하는 데 도움이되기 때문입니다. 그러나 급성기 의료 신드로믹 검사에 사용되는 검사의 특정 유형에는 분자 분석(중합효소 연쇄반응 및 PCR 검사 및 기타), 신속 항원 검사, 혈청학적 검사(항체 검사) 및 기타 진단 방법이 포함됩니다. 검사의 선택은 의심되는 병원체와 임상 상황에 따라 다릅니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 31억 2,000만 달러 |
| 시장 규모 : 2030년 | 46억 7,000만 달러 |
| CAGR : 2025-2030년 | 6.91% |
| 급성장 부문 | 호흡기 질환 |
| 최대 시장 | 아시아태평양 |
감염증 아웃브레이크 증가
다른 진단 검사와의 충돌
포인트 오브 케어 검사(POCT)의 상승
Global Acute Care Syndromic Testing Market was valued at USD 3.12 billion in 2024 and is expected to reach USD 4.67 billion in the forecast period with a CAGR of 6.91% through 2030. Acute Care Syndromic Testing Markets are diagnostic approach used in healthcare settings, particularly in emergency departments and acute care facilities, to rapidly identify and diagnose the cause of acute symptoms or conditions in patients. This approach involves the simultaneous testing of multiple pathogens (such as viruses, bacteria, and other microorganisms) that could be responsible for a patient's symptoms. The goal is to quickly narrow down the potential causes and guide appropriate treatment decisions. Acute care syndromic testing is especially important in situations where patients present with symptoms that could be attributed to various infectious agents. This testing strategy allows healthcare providers to make timely and informed decisions regarding patient care, isolation measures, and treatment options. It can be particularly valuable during disease outbreaks or pandemics, as it helps healthcare systems efficiently manage and respond to a large number of patients with similar symptoms. However, The specific types of tests used in acute care syndromic testing may include molecular assays (like polymerase chain reaction or PCR tests), rapid antigen tests, serological tests (looking for antibodies), and other diagnostic methods. The choice of tests depends on the suspected pathogens and the clinical context.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 3.12 Billion |
| Market Size 2030 | USD 4.67 Billion |
| CAGR 2025-2030 | 6.91% |
| Fastest Growing Segment | Respiratory Disease |
| Largest Market | Asia-Pacific |
Key Market Drivers
Rise in Infectious Disease Outbreaks
The rise in infectious disease outbreaks has a significant impact on driving the growth of the global acute care syndromic testing market. Infectious disease outbreaks create a heightened demand for rapid and accurate diagnostic solutions, and acute care syndromic testing addresses this need. Influenza is the most common infectious disease in the world, but some diseases are more prevalent than others. In the United States alone, about 1 in every 5 people gets the flu every year, but only about 300 people get prion disease each year. Acute care syndromic testing enables healthcare providers to quickly identify the pathogens responsible for the outbreak. Rapid diagnosis allows for early detection and timely implementation of containment measures, such as isolating infected individuals and implementing infection control protocols. During an outbreak, healthcare facilities experience an influx of patients with similar symptoms. Acute care syndromic testing streamlines patient management by providing a comprehensive assessment of the potential pathogens causing the outbreak, allowing for appropriate treatment and care planning. Identifying the causative agent of an outbreak promptly helps limit its spread within the community and healthcare settings. Acute care syndromic testing assists in identifying carriers, isolating cases, and preventing further transmission. Different infectious agents may require specific treatments. Acute care syndromic testing aids in tailoring treatment plans by providing information about the pathogens involved and their susceptibility to different therapies, which can lead to more effective patient outcomes. Outbreaks often strain healthcare resources. Acute care syndromic testing optimizes resource allocation by quickly identifying cases that require immediate attention and enabling efficient use of medical supplies, personnel, and facilities. Infectious disease outbreaks have highlighted the importance of global health security. Acute care syndromic testing is a critical tool in enhancing preparedness and response capabilities, ensuring a rapid and effective response to emerging threats.
The increasing frequency of global outbreaks such as COVID-19, Zika, Ebola, and emerging influenza strains has underscored the urgent need for robust syndromic testing platforms that can detect a wide array of pathogens within hours. This rapid detection is critical not only for individual patient care but also for public health surveillance, enabling governments and health agencies to monitor the spread of infectious diseases in real time. Acute care syndromic testing systems integrate automation, multiplexing, and high-throughput capabilities, allowing labs and emergency departments to manage high patient volumes while ensuring diagnostic accuracy. These innovations have made syndromic testing essential during crisis scenarios where timely responses can mitigate large-scale outbreaks.
According to the World Health Organization (WHO), infectious diseases cause over 17 million deaths annually, with respiratory infections alone accounting for around 4 million of these cases. This staggering burden emphasizes the need for faster diagnostic interventions in acute settings. The global interconnectedness of travel and trade has increased the speed at which pathogens can cross borders, making syndromic testing a critical first line of defense in hospitals and clinics worldwide. As healthcare systems continue to evolve to handle pandemics and antibiotic resistance, the integration of acute care syndromic testing into emergency protocols is likely to become standard practice, driving sustained growth in the market.
Key Market Challenges
Competition from other diagnostic tests
Syndromic testing competes with other diagnostic tests, such as molecular diagnostics and serological diagnostics. These tests may be more accurate and can provide more information about the underlying cause of the syndrome. molecular diagnostics can identify the specific pathogen causing the syndrome, while serological diagnostics can detect the presence of antibodies to the pathogen. This information can be helpful in making a diagnosis and determining the best course of treatment. Healthcare providers may be more accustomed to using traditional diagnostic methods that they are already familiar with, which can lead to a resistance to adopting newer syndromic testing approaches. Diagnostic methods that have a long history of use and established reliability may be favored by healthcare professionals, making it difficult for syndromic testing to gain traction.
Key Market Trends
Rise of Point-of-Care-Testing (POCT)
The rise of Point-of-Care Testing (POCT) is a significant trend in the global Acute Care Syndromic Testing Market. Point-of-Care Testing refers to diagnostic testing performed at or near the patient's location, providing rapid results that can guide immediate clinical decision-making. POCT allows healthcare providers to quickly diagnose and initiate treatment plans, particularly in acute care settings where time is critical. Acute care syndromic testing, when adapted to POCT platforms, enables rapid identification of pathogens responsible for acute symptoms, leading to more timely and appropriate interventions. Syndromic testing conducted at the point of care eliminates the need to send samples to centralized laboratories, reducing turnaround times for results. This speed is essential in managing acute conditions and outbreaks, where rapid decisions are crucial. Point-of-care syndromic testing empowers healthcare providers to make informed decisions at the bedside. Immediate results help guide isolation measures, treatment choices, and patient management strategies, improving overall care. In situations such as infectious disease outbreaks, POCT-based acute care syndromic testing can contribute to rapid containment by quickly identifying cases and implementing appropriate control measures to prevent further spread. POCT helps optimize resource allocation by avoiding unnecessary transfers, repeat tests, and prolonged hospital stays. This efficiency is especially relevant in acute care scenarios where resources may be limited. During events like large gatherings or disaster response, point-of-care syndromic testing can provide rapid screening for infectious diseases, aiding in quick identification and management of potential outbreaks. POCT can be particularly valuable in remote or underserved regions with limited access to central laboratories. Acute care syndromic testing at the point of care bridges the gap in diagnostic capabilities. Real-time Surveillance: Point-of-care syndromic testing generates data that can be analyzed in real time, contributing to disease surveillance efforts, early detection of emerging pathogens, and timely public health responses.
Abbott Laboratories
Becton, Dickinson and Company
Biocartis NV
bioMerieux SA (BioFire Diagnostics)
Danaher Corporation (Cepheid, Inc.)
DiaSorin S.p.A (Luminex Corporation)
Eurofins Scientific (Eurofins Viracor)
Hologic Inc.
Laboratory Corporation of America Holdings.
QIAGEN N.V.
In this report, the Global Acute Care Syndromic Testing Markets Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Major companies present in the Global Acute Care Syndromic Testing Market.
Global Acute Care Syndromic Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: